Versant Capital Management, Inc I Teos Therapeutics, Inc. Transaction History
Versant Capital Management, Inc
- $578 Million
- Q1 2025
A detailed history of Versant Capital Management, Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 985 shares of ITOS stock, worth $7,239. This represents 0.0% of its overall portfolio holdings.
Number of Shares
985Holding current value
$7,239% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ITOS
# of Institutions
148Shares Held
33.3MCall Options Held
454KPut Options Held
2.45M-
Black Rock Inc. New York, NY3.73MShares$27.4 Million0.0% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$20.1 Million16.91% of portfolio
-
Bvf Inc San Francisco, CA2.33MShares$17.1 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.09MShares$15.4 Million0.26% of portfolio
-
Jpmorgan Chase & CO New York, NY2.07MShares$15.2 Million0.0% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $261M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...